Yes, Semaglutide, in a group of peptides called GLP-1 agonists", was initially FDA approved only for Type 2 diabetes, but it gained an additional approval by the FDA in June 2021 specifically for weight loss in patients who are not diabetic
Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
Why should I avoid green tea
Approved by the FDA for type 2 diabetes and chronic weight management, tirzepatide (Mounjaro, Zepbound) is administered as a weekly subcutaneous injection
A 20 mg total vial gives about 40 draws at 0.5 mg, 20 draws at 1 mg, or 10 draws at 2 mg
This means not all of what you swallow gets absorbed at the cellular level